new glp-1 drugs Diabetes advocacy group discourages use of compounded Medicare GLP-1 Drug Coverage -

Zhang G, Wang Z, Yu H, Liu X

HSP, heat shock protein

61 ECC5004 The preliminary results of the investigational agent ECC5004 phase 1 trial in non-human primates revealed a reduction in HbA1c levels, accompanied by weight loss and a decreased risk of adverse cardiovascular events, achieved through the mimicry of the hormone GLP-1

It is always a huge letdown when they ask me if the patches work and I have to explain that there is no clinical evidence behind them

Im not saying one is healthier than the other but what I am saying is that they all have the potential to help you lose weight

doi: 10.1016/j.pharmthera.2020.107503